Anspor
Active Ingredient(s): CephradineFDA Approved: * October 1, 1974
Pharm Company: * GLAXOSMITHKLINE
Category: Antibiotics
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Anspor Overview
Cefradine (INN) or cephradine (BAN) is a first generation cephalosporin antibiotic.[1] Contents 1 Indications 2 Formulations 3 Synthesis 4 Production names 5 See also 6 Notes 7 References Indications Respiratory tract infections (such as tonsillitis, pharyngitis, and lobar pneumonia) caused by group A beta-hemolytic streptococci and S. pneumoniae (formerly D. pneumonia).[note 1] Otitis media caused by group A beta-hemolytic streptococci, S. pneumoniae, ...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cefradine
Recent Anspor Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Cephradine
- Capsule: 250mg, 500mg
- For Suspension: 125mg/5ml, 250mg/5ml
- Powder for Reconstitution: 250mg/5ml